SCHEMBL26048823

SCHEMBL26048823

CC1CN(c2ccc(F)cn2)C1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM1 Q13255 2/20 0.47
GPR119 Q8TDV5 1/20 0.45
CNR2 P34972 1/20 0.43
HCRTR1 O43613 1/20 0.42
HCRTR2 O43614 1/20 0.42
DHFR P00374 1/20 0.42
HRH3 Q9Y5N1 2/20 0.41
CHIA Q9BZP6 1/20 0.41
SLC6A9 P48067 3/20 0.39
MAPT P10636 1/20 0.39
HTR1A P08908 1/20 0.39
DRD4 P21917 1/20 0.39
HTR2A P28223 1/20 0.39
SLC6A4 P31645 1/20 0.39
HTR7 P34969 1/20 0.39
DRD3 P35462 1/20 0.39
PDK2 Q15119 2/20 0.38
PDK1 Q15118 1/20 0.38
F2RL1 P55085 1/20 0.37
CHRM1 P11229 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23019809 0.84 KMT2A (0.51) GRM1GPR119HCRTR1HCRTR2CHIA
SCHEMBL20004006 0.84 KMT2A (0.51) GRM1GPR119HCRTR1HCRTR2CHIA
SCHEMBL18022508 0.84 ADRA1A (0.52) GRM1GPR119HRH3CHIASLC6A9
SCHEMBL19775600 0.84 ADRA1A (0.52) GRM1GPR119HRH3CHIASLC6A9
SCHEMBL22755219 0.82 MAPT (0.57) GRM1GPR119DHFRHRH3CHIA
SCHEMBL20064022 0.81 GRM1 (0.47) GRM1GPR119HCRTR1HCRTR2DHFR
SCHEMBL26048795 0.81 HRH3 (0.44) GRM1GPR119HCRTR1HCRTR2DHFR
SCHEMBL23046561 0.81 GRM1 (0.44) GRM1GPR119HCRTR1HCRTR2DHFR
SCHEMBL10154595 0.79 GRIN2D (0.49) GPR119CNR2DHFRHRH3MAPT
SCHEMBL20157231 0.79 CHRNB4 (0.49) GRM1HCRTR1HCRTR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230365592-A1 COMPOUNDS AND METHODS USEFUL FOR STABILIZING PHENYLALANINE HYDROXYLASE MUTATIONS AGIOS PHARMACEUTICALS, INC. 2023-11-16 US disclosed
US-20230365592-A1 COMPOUNDS AND METHODS USEFUL FOR STABILIZING PHENYLALANINE HYDROXYLASE MUTATIONS AGIOS PHARMACEUTICALS, INC. 2023-11-16 US disclosed
US-20230339980-A1 COMPOUNDS AND METHODS USEFUL FOR STABILIZING PHENYLALANINE HYDROXYLASE MUTATIONS AGIOS PHARMACEUTICALS, INC. (US) 2023-10-26 US disclosed
WO-2023164235-A1 COMPOUNDS AND METHODS USEFUL FOR STABILIZING PHENYLALANINE HYDROXYLASE MUTATIONS AGIOS PHARMACEUTICALS, INC. (US) 2023-08-31 WO disclosed
WO-2023164237-A1 COMPOUNDS AND METHODS USEFUL FOR STABILIZING PHENYLALANINE HYDROXYLASE MUTATIONS AGIOS PHARMACEUTICALS, INC. (US) 2023-08-31 WO disclosed
WO-2023164233-A1 (4-BENZO[D]OXAZOL-2-YL)-6,7-DIHYDRO-1H-IMIDAZO[4,5-C]PYRIDINE-5(4H)-YL)METHANONE DERIVATIVES AS MUTANT PAH STABILIZERS FOR THE TREATMENT OF PHENYLKETONURIA AGIOS PHARMACEUTICALS, INC. (US) 2023-08-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230365592-A1 COMPOUNDS AND METHODS USEFUL FOR STABILIZING PHENYLALANINE HYDROXYLASE MUTATIONS PAH, KDM8, PHF8 GRM1 3392/4885GPR119 2220/4885CNR2 4637/4885
US-20230339980-A1 COMPOUNDS AND METHODS USEFUL FOR STABILIZING PHENYLALANINE HYDROXYLASE MUTATIONS PAH, KDM8, PHF8 GRM1 3392/4885GPR119 2220/4885CNR2 4637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.